Pliant Therapeutics (PLRX)

Pliant Therapeutics (PLRX) Stock Price & Analysis


PLRX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$14.47 - $36.64
Previous Close$17.06
Average Volume (3M)649.96K
Market Cap
Enterprise Value$419.72M
Total Cash (Recent Filing)$555.16M
Total Debt (Recent Filing)$14.54M
Price to Earnings (P/E)-6.2
Nov 07, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.74
Shares Outstanding59,834,098
10 Day Avg. Volume1,075,797
30 Day Avg. Volume649,963
Standard Deviation0.29
Financial Highlights & Ratios
Price to Book (P/B)1.95
Price to Sales (P/S)4116.01
Price to Cash Flow (P/CF)-10.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue83.49
Enterprise Value/Gross Profit43.34
Enterprise Value/Ebitda-2.58
Price Target Upside191.99% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Pliant Therapeutics’s price range in the past 12 months?
Pliant Therapeutics lowest stock price was $14.47 and its highest was $36.64 in the past 12 months.
    What is Pliant Therapeutics’s market cap?
    Currently, no data Available
    When is Pliant Therapeutics’s upcoming earnings report date?
    Pliant Therapeutics’s upcoming earnings report date is Nov 07, 2023 which is in 34 days.
      How were Pliant Therapeutics’s earnings last quarter?
      Pliant Therapeutics released its earnings results on Aug 09, 2023. The company reported -$0.7 earnings per share for the quarter, beating the consensus estimate of -$0.713 by $0.013.
        Is Pliant Therapeutics overvalued?
        According to Wall Street analysts Pliant Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Pliant Therapeutics pay dividends?
          Pliant Therapeutics does not currently pay dividends.
          What is Pliant Therapeutics’s EPS estimate?
          Pliant Therapeutics’s EPS estimate is -$0.77.
            How many shares outstanding does Pliant Therapeutics have?
            Pliant Therapeutics has 59,834,100 shares outstanding.
              What happened to Pliant Therapeutics’s price movement after its last earnings report?
              Pliant Therapeutics reported an EPS of -$0.7 in its last earnings report, beating expectations of -$0.713. Following the earnings report the stock price went up 3.3%.
                Which hedge fund is a major shareholder of Pliant Therapeutics?
                Among the largest hedge funds holding Pliant Therapeutics’s share is RA Capital Management. It holds Pliant Therapeutics’s shares valued at 32M.


                  Pliant Therapeutics Stock Smart Score

                  The Pliant Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Pliant Therapeutics

                  Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.


                  Top 5 ETFs holding PLRX

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Schwab U.S. Broad Market ETF
                  iShares Russell 3000 ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold PLRX. The ETFs are listed according to market value of PLRX within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Ascendis Pharma
                  Axsome Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis